Carasent AB (publ) (STO:CARA)
22.95
-1.20 (-4.97%)
Apr 14, 2026, 5:29 PM CET
Carasent AB Market Cap
Carasent AB has a market cap or net worth of 1.65 billion as of April 14, 2026. Its market cap has increased by 10.45% in one year.
Market Cap
1.65B
Enterprise Value
1.55B
Revenue
343.82M
Ranking
n/a
PE Ratio
48.30
Stock Price
22.95
Market Cap Chart
Since December 12, 2012, Carasent AB's market cap has increased from 48.86M to 1.65B, an increase of 3,284.33%. That is a compound annual growth rate of 30.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.65B | -13.87% |
| Dec 30, 2025 | 1.92B | 19.57% |
| Dec 30, 2024 | 1.61B | 3,186.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 140.41B |
| Getinge AB | 52.28B |
| Sectra AB | 45.32B |
| Camurus AB | 30.74B |
| Cereno Scientific AB | 2.01B |
| Stille AB | 2.00B |
| EQL Pharma AB | 1.64B |
| Surgical Science Sweden AB | 1.61B |